Forskning
- Biomaterialer, Biokompatibilitet
- Nanomaterialer
- Biologiske effekter til biomaterialer og nanomaterialer
- Nanotoksikologi
- Nanomedisin
- Utvikling av nye metoder for å undersøke biologiske effekter av nanomaterialer
Undervisning
tannlegestudenter, tannpleierstudenter, spesialistkandidater, PhD kandidater, BSc og MSc studenter i Nanoteknologi og Nanovitenskap
Prosjekter
"A common European approach to the regulatory testing of nanomaterials" NANoREG -finansiert av FP7 European Framework Program on Nanoscience, Nanotechnologies, Materials and New Production Technologies (2013-2017) - Principal investigator v/UiB
“National initiative towards developing a common approach to the regulatory testing of manufactured nanomaterials” (NorNANoREG) – finansiert av Norsk forskningsråd, NANO2021 programmet (2014-2017) - Principal investigator v/UiB og task leder
“Self-navigated integrin receptors seeking "thermally-smart" multifunctional few-layer graphene-encapsulated magnetic nanoparticles for molecular MRIguided anticancer treatments in "real time" personalized nanomedicine (GEMNS)” (2015 -2018) - finansiert av EuroNanoMed II, gjennom EC’s 7th Framework Programme - Principal investigator v/UiB og leder av norske deltakere
"Development of impedance-based non-invasive techniques for evaluating the biological effects of nanoparticles" (2013-2016) - finansiert av UH-nett Vest
“Innovative Nanopharmaceuticals: Targeting breast cancer stem cells by a novel combination of epigenetic and anticancer drugs with gene therapy
(INNOCENT)” (2017-2020) - finansiert av EuroNanoMed II, gjennom EC’s 7th Framework Programme - Principal investigator v/UiB
"Science-based Risk Governance of Nano-Technology" (RiskGone) (2019-2023) - finansiert av HORIZON2020 (H2020-NMBP-13-2018 RIA, grant agreement nr. 814425) - WP co-leader
"Towards a reliable assessment of nanomaterial health effects using advanced biological models and assays" (NanoBioReal) (2019-2022) - finansiert av Norsk forskningsråd, NANO2021 programmet - Coordinator
COST action "Nano2Clinic" - Partner